C12N 2760/20045
Special targeting system for viral vectors
C12N2760/20045 (Special targeting system for viral vectors) appears on 2 US grants and 7 published applications in this corpus.
Search patents in C12N- Granted patents
- 2
- Published applications
- 7
- Assignees
- 6
- Inventors
- 9
- Latest grant
- 21 Feb 2017
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2011 | 0 | 1 |
| 2012 | 0 | 0 |
| 2013 | 1 | 0 |
| 2014 | 0 | 2 |
| 2015 | 0 | 0 |
| 2016 | 0 | 0 |
| 2017 | 1 | 1 |
| 2018 | 0 | 1 |
| 2019 | 0 | 0 |
| 2020 | 0 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 0 |
| 2023 | 0 | 0 |
| 2024 | 0 | 0 |
| 2025 | 0 | 1 |
By publication year.
Recent patents
- Modified rhabdovirus glycoproteins and uses thereof6 Nov 2025US 2025/0339384 A1Regeneron Pharmaceuticals, Inc.
- Oncolytic rhabdovirus24 Jun 2021US 2021/0187048 A1Turnstone Limited Partnership
- Oncolytic rhabdovirus27 Dec 2018US 2018/0369303 A1Turnstone Limited Partnership
- Oncolytic rhabdovirus15 Jun 2017US 2017/0165305 A1Turnstone Limited Patnership
- Oncolytic rhabdovirus6 Feb 2014US 2014/0037584 A1Children's Hospital of Eastern Ontario Research Institute Inc.
Most cited
By later US patents
No patent in this class has been cited by a later US patent yet.